NCT05526690View on ClinicalTrials.gov

Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

December 12, 2020

Study Completion Date

December 12, 2020

Conditions
Hypertension
Interventions
DRUG

Metformin

1000 mg dose of immediate-release metformin

DRUG

CIN-107

10 mg dose of CIN-107

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY